Loading company…
Riskpilot
← Back to search
Sign in
Get full access
GENTIAN AS
AS
Active
Org 979819234
Bjørnåsveien 5, 1596 Moss
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 1998
53 employees
www.gentian.no
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 138M
+17% vs 2023
EBITDA margin
34.3%
+166% vs 2023
Equity ratio
71.9%
Financial strength
Net profit 2024
NOK 60,3M
+3504% vs 2023
EBITDA — year on year
NOK millions
59M
42M
24M
7M
-10M
-8M
2020
-1M
+88%
2021
1M
+200%
2022
18M
+1700%
2023
47M
+161%
2024
Key figures
Annual report 2024
Revenue
NOK 138M
+17%
EBITDA
NOK 47,3M
+166%
Net profit
NOK 60,3M
+3504%
Total assets
NOK 179,4M
+62%
Equity
NOK 129M
+1729%
Employees
53
—
Company information
Legal name
GENTIAN AS
Org number
979819234
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
30. april 1998
Share capital
NOK 20 000 000
Employees
53 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Contact
Address
Bjørnåsveien 5, 1596 Moss
Phone
+4799339905
Email
info@gentian.com
Website
www.gentian.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Moss
All Norway companies
Revenue
NOK millions
0M
40M
79M
119M
159M
62M
2020
85M
2021
96M
2022
118M
2023
138M
2024
EBITDA
NOK millions
0M
14M
27M
41M
54M
-8M
2020
-1M
2021
1M
2022
18M
2023
47M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
61 572
85 258
96 422
118 225
138 045
Staff expenses
−40 838
−42 548
−43 710
−50 441
−51 852
EBITDA
−7 565
−1 260
956
17 753
47 281
Depreciation & amort.
−6 530
−7 672
−10 156
−15 890
−8 753
EBIT
−14 095
−8 932
−9 199
1 863
38 527
Net financials
−603
−2 458
−3 891
−3 635
−3 424
Profit before tax
−14 698
−11 390
−13 090
−1 772
35 104
Tax
−0
−0
−0
−0
−25 229
Net profit
−14 698
−11 390
−13 090
−1 772
60 333
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
88 185
113 541
124 503
111 011
179 418
Equity
30 289
19 857
8 379
7 051
128 967
Long-term debt
41 379
78 634
97 661
85 718
23 865
Short-term debt
16 517
15 050
18 464
18 243
26 587
Total debt
57 896
93 684
116 124
103 960
50 451
Financial ratios
5-year trend
EBITDA margin
34.3%
This company
15.8%
Market median
+117% vs market
2020
2024
Equity ratio
71.9%
This company
38.2%
Market median
+88% vs market
2020
2024
Return on equity
46.8%
This company
18.4%
Market median
+154% vs market
2020
2024
Net profit margin
43.7%
This company
8.1%
Market median
+440% vs market
2020
2024
Asset turnover
0.77×
This company
1.12×
Market median
-31% vs market
2020
2024
Debt / equity
0.39×
This company
0.62×
Market median
+37% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
NK
Njaal Kind
Chief Executive Officer
Chief Executive Officer
2024
Board of directors
Non-executive oversight
Name
Role
Member since
Former (1)
HI
Hilja Ibert
Chairman
2018 – 2024
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Gentian Diagnostics Asa
Company
100%
100%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Vatne Capital As
Vatne Equity As
Gentian Diagnostics Asa
GENTIAN AS
(this company)
Board network connections
Board members of GENTIAN AS also hold positions in
0
other companies.
Person
Role here
Other companies
Njaal Kind
Chief Executive Officer
0 companies
Hilja Ibert
Chairman
0 companies